Currently out of the existing stock ratings of Vik Chopra, 21 are a HOLD (52.5%), 19 are a BUY (47.5%).

Vik Chopra

Work Performance Price Targets & Ratings Chart

Analyst Vik Chopra, currently employed at WELLS FARGO, carries an average stock price target met ratio of 50.42% that have a potential upside of 11.65% achieved within 72 days.

Vik Chopra’s has documented 80 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on XRAY, Dentsply Sirona at 28-Feb-2025.

Wall Street Analyst Vik Chopra

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for IART (INTEGRA LIFESCIENCES HOLDINGS) at 5/6/2024. The price target of $25 was fulfilled within 1 day with a profit of $1.86 (8.04%) receiving and performance score of 80.38.

Average potential price target upside

of $11.4 (8.04%) on MASI (MASIMO).
of $10.82 (17.35%) on CNMD (CONMED).
of $6.61 (10.38%) on GMED (GLOBUS MEDICAL).

ENOV Enovis Corp GMED Globus Medical MASI Masimo NUVA NuVasive HSIC Henry Schein CNMD CONMED IART Integra LifeSciences Holdings NPCE Neuropace NVST Envista Holdings Corp XRAY Dentsply Sirona

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Mike Matson (NEEDHAM)